相关实验视频

Updated: Jan 13, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

解码神经递质和基因对抗N-甲基-D-酸盐受体脑炎中神经元信号异常的贡献:针对性疗法的影响

Rong Guo¹, Wenjia Wang¹, Rui Qian¹

¹Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.

Brain research bulletin

|January 8, 2026

概括

这项研究揭示了一种与抗N-甲基-D-酸盐受体 (NMDAR) 脑炎中大脑功能变化相关的基因表达模式. 这些发现为未来的研究和个性化治疗提供了潜在的分子标.

科学领域:

神经科学是一个神经科学.
基因组学就是基因组学.
计算生物学计算生物学

背景情况:

抗N-甲基-D-酸盐受体 (NMDAR) 脑炎是一种自身免疫神经系统疾病.
在这种情况下,连接大脑功能变化和基因表达的分子基础尚未得到充分理解.

研究的目的:

研究大脑活动模式 (CV_BOLD,FC) 与抗NMDAR脑炎中的基因表达之间的关系.
识别与观察到的大脑功能变化相关的特定基因和神经递质系统.

主要方法:

在患者和对照组中分析血液氧化水平依赖信号 (CV_BOLD) 和功能连接 (FC) 的变化系数.
应用五种机器学习模型进行分类.
转录组数据和神经递质密度图的整合.
部分最小平方回归 (PLS) 和多变量线性回归用于基因表达和神经递质分析.

主要成果:

患者在特定的大脑区域的CV_BOLD增加,并在关键网络内功能连接 (FC) 受到干扰.
PLS分析确定了2320个与CV_BOLD/FC变化显著相关的基因,丰富了突触信号传递,代谢调节和神经退行途径.
上腺素显著影响了CV_BOLD,而其他神经递质则影响了FC.

结论:

一个明显的转录特征在空间上与抗NMDAR脑炎中的大脑功能异常和神经递质分布有关.
这项研究产生了与机械学研究和精密医学治疗脑炎治疗方法相关的分子点的假设.

关键词:

抗NMDAR脑炎的治疗方法血液氧化水平取决于系数变化信号的变化系数.功能连接性的功能连接性.机器学习是机器学习.神经递质是神经递质中的一种.文字转录学 (Transcriptomics) 是一个学科.

更多相关视频

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

相关概念视频

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...